Angiogenesis 2024: Utilizing longitudinal AI-based fluid quantification for at-home monitoring
February 3rd 2024In conversation with Ophthalmology Times Europe, Anat Loewenstein, MD, illuminates the outcomes of using an AI-based fluid quantification for remote retina monitoring and analysis.
Read More
AAO 2023: Retinal visualization and patients who've had small aperture IOL implantation
November 20th 2023Mark Blecher, MD, spoke with the Ophthalmology Times team about his poster addressing retinal visualization and patients who've had small aperture IOL implantation at this year's American Academy of Ophthalmology meeting.
Read More
Biocon’s YESAFILI is intended for treatment of a number of ocular conditions, including neovascular AMD, visual impairment due to myopic choroidal neovascularisation, visual impairment due to DME and visual impairment due to macular edema secondary to retinal vein occlusion.
Read More
EMA approves Clinical Trial Application for retinitis pigmentosa therapy from ViGeneron
August 23rd 2023European Medicines Agency issued approval for a Clinical Trial Application of its new gene therapy, VG901, which uses an adeno-associated virus vector to treat CNGA1-associated retinitis pigmentosa.
Read More